跳至主要内容
临床试验/NL-OMON47511
NL-OMON47511
已完成
4 期

Strengthening memory immunity in the aged population by vaccinating pre-elderly - StimulAge study

RIVM0 个研究点目标入组 207 人待定

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
virale infectziekten (niet meer in te vullen boven)
发起方
RIVM
入组人数
207
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
去年
研究类型
Interventional

研究者

发起方
RIVM

入排标准

入选标准

  • In order to be eligible to participate in this study, participants must meet
  • all of the following criteria:
  • \* General good health
  • \* 50\-65 years of age
  • \* Provision of written informed consent;
  • \* Adherent to protocol and available during the study period.

排除标准

  • Any of the following criteria will exclude a participant from this study:, \*
  • Antibiotic use within 14 days of enrollment;
  • \* Present evidence of serious disease(s) demanding immunosuppressive medical
  • treatment, like corticosteroids, that might interfere with the results of the
  • study within the last 3 months;
  • \* Known or suspected allergy to any of the vaccine components (by medical
  • \* Occurrence of serious adverse event after other vaccination (by medical
  • \* Known or suspected immune deficiency;
  • \* History of any neurologic disorder, including epilepsy;\* Known or suspected coagulation disorder;
  • \* Previous administration of serum products (including immunoglobulins) within

结局指标

主要结局

未指定

相似试验